XML 26 R16.htm IDEA: XBRL DOCUMENT

Fair Value

3 Months Ended

Mar. 31, 2024

(9) Fair Value

The Company is required to disclose fair value information about financial instruments, whether or not recognized at fair value on the face of the balance sheet, for which it is practicable to estimate that value. The assumptions used in the estimation of the fair value of the Company’s financial instruments are detailed below. Where quoted prices are not available, fair values are based on estimates using discounted cash flows and other valuation techniques. The use of discounted cash flows can be significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. The following disclosures should not be considered a surrogate of the liquidation value of the Company, but rather a good faith estimate of the increase or decrease in the value of financial instruments held by the Company since purchase, origination, or issuance.

The Company groups assets and liabilities at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are:

	·	Level 1 – Valuation is based upon quoted prices for identical instruments traded in active markets.
	·	Level 2 – Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.
	·	Level 3 – Valuation is generated from model-based techniques that use at least one significant assumption not observable in the market. These unobservable assumptions reflect estimates of assumptions that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow models and similar techniques.

Investment Securities Available for Sale

Fair values of investment securities available for sale are determined by obtaining quoted prices on nationally recognized securities exchanges when available. If quoted prices are not available, fair value is determined using matrix pricing, which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted securities. Fair values for investment securities with quoted market prices are reported in the Level 1 fair value category. Fair value measurements obtained from independent pricing services are reported in the Level 2 fair value category. All other fair value measurements are reported in the Level 3 fair value category.

Mortgage Loans Held for Sale

Mortgage loans held for sale are carried at lower of aggregate cost or market value. The cost of mortgage loans held for sale approximates the market value. Mortgage loans held for sale are reported in the Level 2 fair value category. Management determined that the valuation technique used at current period end and prior period end are more appropriately classified as Level 2 and has updated in the current period and prior period year end classifications to Level 2.

Loans

The fair value of loans, excluding previously presented individually evaluated loans measured at fair value on a non-recurring basis, is estimated using discounted cash flow analyses. The discount rates used to determine fair value use interest rate spreads that reflect factors such as liquidity, credit, and nonperformance risk of the loans. Loans are reported in the Level 3 fair value category, as the pricing of loans is more subjective than the pricing of other financial instruments.

Mutual Funds

For mutual funds held in the deferred compensation trust, the carrying value is a reasonable estimate of fair value. Mutual funds held in the deferred compensation trust are included in other assets on the balance sheet and reported in the Level 1 fair value category.

FHLB Borrowings

The fair value of FHLB borrowings is estimated based upon discounted future cash flows using a discount rate comparable to the current market rate for such borrowings. FHLB borrowings are reported in the Level 2 fair value category. Management determined that the valuation technique used at current period end and prior period end are more appropriately classified as Level 2 and has updated in the current period and prior period year end classifications to Level 2.

Commitments to Extend Credit and Standby Letters of Credit

Commitments to extend credit and standby letters of credit are generally short-term in duration and made at variable interest rates. Therefore, both the carrying value and estimated fair value associated with these instruments are immaterial.

Limitations

Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument. Because no market exists for a significant portion of the Company’s financial instruments, fair value estimates are based on many judgments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

Fair value estimates are based on existing on and off-balance sheet financial instruments without attempting to estimate the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments. Significant assets and liabilities that are not considered financial instruments include deferred income taxes and premises and equipment. In addition, the tax ramifications related to the realization of unrealized gains and losses can have a significant effect on fair value estimates and have not been considered in the estimates.

The tables below present all financial instruments measured at fair value on a recurring basis by level within the fair value hierarchy, as of March 31, 2024 and December 31, 2023.

(Dollars in thousands)
		March 31, 2024
		Fair Value				Level 1 Valuation				Level 2 Valuation				Level 3 Valuation
U.S. Treasuries		$	7,086				-				7,086				-
U.S. Government sponsored enterprises			10,044				-				10,044				-
GSE - Mortgage-backed securities			237,116				-				237,116				-
Private label mortgage-backed securities			35,352				-				35,352				-
State and political subdivisions			105,066				-				105,066				-

(Dollars in thousands)
		December 31, 2023
		Fair Value				Level 1 Valuation				Level 2 Valuation				Level 3 Valuation
U.S. Treasuries		$	9,814				-				9,814				-
U.S. Government
Sponsored enterprises			11,539				-				11,539				-
Mortgage-backed securities			273,838				-				273,838				-
State and political subdivisions			150,203				-				150,203				-
Mutual funds held in deferred compensation trust			1,327				-				1,327

The fair value measurements for mortgage loans held for sale and individually evaluated loans on a non-recurring basis at March 31, 2024 and December 31, 2023 are presented below. The fair value measurement process uses certified appraisals and other market-based information; however, in many cases, it also requires significant input based on management’s knowledge of, and judgment about, current market conditions, specific issues relating to the collateral and other matters. As a result, all fair value measurements for individually evaluated loans and other real estate are considered Level 3.

(Dollars in thousands)
		Fair Value Measurements March 31, 2024				Level 1 Valuation				Level 2 Valuation				Level 3 Valuation
Individually evaluated loans		$	467				-				-				467

(Dollars in thousands)

Fair Value Measurements December 31, 2023

Level 1 Valuation

Level 2 Valuation

Level 3 Valuation

Individually evaluated loans

$

-

-

-

-

(Dollars in thousands)

Fair Value

March 31, 2024

Fair Value

December 31, 2023

Valuation

Technique

Significant Unobservable Inputs

General Range of Significant Unobservable Input Values

Individually evaluated loans

$

467

$

-

Appraised value

Discounts to reflect current market conditions and ultimate collectability

0 - 25%

The carrying amount and estimated fair value of financial instruments at March 31, 2024 and December 31, 2023 are as follows:

(Dollars in thousands)
						Fair Value Measurements at March 31, 2024
		Carrying Amount				Level 1				Level 2				Level 3				Total
Assets:
Cash and cash equivalents		$	98,096				98,096				-				-				98,096
Investment securities available for sale			394,664				-				394,664				-				394,664
Other investments			2,858				-				-				2,858				2,858
Mortgage loans held for sale			1,292				-				1,292				-				1,292
Loans, net			1,095,823				-				-				1,083,635				1,083,635
Mutual funds held in deferred
compensation trust			2,394				2,394				-				-				2,394

Liabilities:
Deposits		$	1,452,364				-				1,456,401				-				1,456,401
Securities sold under agreements
to repurchase			59,216				-				59,216				-				59,216
Junior subordinated debentures			15,464				-				15,464				-				15,464

(Dollars in thousands)
						Fair Value Measurements at December 31, 2023
		Carrying Amount				Level 1				Level 2				Level 3				Total
Assets:
Cash and cash equivalents		$	82,375				82,375				-				-				82,375
Investment securities available for sale			391,924				-				391,924				-				391,924
Other investments			2,874				-				-				2,874				2,874
Mortgage loans held for sale			686				-				686				-				686
Loans, net			1,082,025				-				-				1,071,178				1,071,178
Mutual funds held in deferred
compensation trust			2,171				2,171				-				-				2,171

Liabilities:
Deposits		$	1,392,045				-				1,397,351				-				1,397,351
Securities sold under agreements
to repurchase			86,715				-				86,715				-				86,715
Junior subordinated debentures			15,464				-				15,464				-				15,464

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details